College of Pharmacy, Department of Clinical Sciences and Administration, University of Houston, Houston, TX 77030, USA.
Value Health. 2009 Nov-Dec;12(8):1062-73. doi: 10.1111/j.1524-4733.2009.00602.x. Epub 2009 Sep 29.
Most contemporary epidemiologic studies require complex analytical methods to adjust for bias and confounding. New methods are constantly being developed, and older more established methods are yet appropriate. Careful application of statistical analysis techniques can improve causal inference of comparative treatment effects from nonrandomized studies using secondary databases. A Task Force was formed to offer a review of the more recent developments in statistical control of confounding.
The Task Force was commissioned and a chair was selected by the ISPOR Board of Directors in October 2007. This Report, the third in this issue of the journal, addressed methods to improve causal inference of treatment effects for nonrandomized studies.
The Task Force Report recommends general analytic techniques and specific best practices where consensus is reached including: use of stratification analysis before multivariable modeling, multivariable regression including model performance and diagnostic testing, propensity scoring, instrumental variable, and structural modeling techniques including marginal structural models, where appropriate for secondary data. Sensitivity analyses and discussion of extent of residual confounding are discussed.
Valid findings of causal therapeutic benefits can be produced from nonrandomized studies using an array of state-of-the-art analytic techniques. Improving the quality and uniformity of these studies will improve the value to patients, physicians, and policymakers worldwide.
大多数当代流行病学研究需要复杂的分析方法来调整偏差和混杂。新方法不断被开发出来,而更古老、更成熟的方法仍然适用。仔细应用统计分析技术可以提高使用二级数据库的非随机研究中对比较治疗效果的因果推断。一个工作组成立,旨在对混杂控制的更近期统计方法发展进行综述。
该工作组由 ISPOR 董事会于 2007 年 10 月委托并任命主席。本报告是该期刊的第三期,讨论了改善非随机研究中治疗效果因果推断的方法。
工作组报告建议了一般分析技术和特定的最佳实践,在达成共识的地方包括:在多变量建模之前使用分层分析、包括模型性能和诊断测试的多变量回归、倾向评分、工具变量和结构建模技术,包括适当的二次数据的边缘结构模型。还讨论了敏感性分析和残余混杂程度的讨论。
使用一系列最先进的分析技术,可以从非随机研究中得出治疗效果的有效因果发现。提高这些研究的质量和一致性将提高对全球患者、医生和政策制定者的价值。